HilleVax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch HilleVax and buy or sell other stocks, ETFs, and their options commission-free!

About HLVX

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. 

CEO
Robert M. Hershberg, MD, PhD
CEORobert M. Hershberg, MD, PhD
Employees
Employees
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2020
Founded2020
Employees
Employees

HLVX Key Statistics

Market cap
104.76M
Market cap104.76M
Price-Earnings ratio
-1.46
Price-Earnings ratio-1.46
Dividend yield
Dividend yield
Average volume
333.91K
Average volume333.91K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$2.17
52 Week high$2.17
52 Week low
$1.34
52 Week low$1.34

Stock Snapshot

HilleVax(HLVX) stock is priced at $2.09, giving the company a market capitalization of 104.76M. It carries a P/E multiple of -1.46.

During the trading day, HilleVax(HLVX) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 333.91K.

The stock's 52-week range extends from a low of $1.34 to a high of $2.17.

The stock's 52-week range extends from a low of $1.34 to a high of $2.17.

People also own

Based on the portfolios of people who own HLVX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.